Elsevier

Neuroscience Letters

Volume 280, Issue 1, 11 February 2000, Pages 13-16
Neuroscience Letters

Two distinctive antinociceptive systems in rats with pathological pain

https://doi.org/10.1016/S0304-3940(99)00998-2Get rights and content

Abstract

A common obstacle in clinical management of pathological pain is the poor response to opioid analgesics. We now report that Δ9-tetrahydrocannabinol (Δ9-THC)-induced antinociception remained effective in rats with pathological pain. The selective central cannabinoid receptor antagonist SR141716A, but not the generic opioid receptor antagonist naloxone, blocked the Δ9-THC antinociception. Moreover, there is no cross-tolerance between the antinociceptive effects of morphine and Δ9-THC in pathological pain states. The results indicate that Δ9-THC antinociception is both effective and independent of opioid receptors in rats with pathological pain. Thus, the cannabinoid analgesic system may be superior to opioids in alleviating intractable pathological pain syndromes.

Section snippets

Acknowledgements

This work was supported by the PHS grant DA08835. Δ9-tetrahydrocannabinol was kindly provided by Dr. Bill Martin at Medical College of Virginia.

Cited by (99)

  • Skin β-endorphin mediates addiction to UV light

    2014, Cell
    Citation Excerpt :

    Here, naloxone was sufficient to induce conditioned place aversion in UV-irradiated mice, suggesting that chronic UV exposure imparts an opioid-like physical dependence of sufficient magnitude to guide proactive behavior choices. To test for the other principal feature of chronic opioid exposure, tolerance, after chronic UV treatment, we asked whether there is cross-tolerance between chronic UV exposure and morphine, altering the dose required to produce analgesia (Mao et al., 2000). After chronic UV exposure, mice required significantly higher doses of morphine than mock-treated controls to achieve comparable thermal analgesia in the hot-plate test, as reflected by a rightward shift in the dose-response curve and an increase in half-maximal effective concentration from 57 μg/kg in the mock-treated group to 270 μg/kg in the UV-exposed group (Figure 3C).

View all citing articles on Scopus
View full text